Answer to Question 1
Correct Answer: 2
Rationale 1: Niacin does not prevent peripheral neuropathy.
Rationale 2: Pyridoxine prevents peripheral neuropathy.
Rationale 3: Cyanocobalamin does not prevent peripheral neuropathy.
Rationale 4: Neurontin does not prevent neuropathy.
Global Rationale: Pregnant patients should receive isoniazid therapy supplemented with pyridoxine (vitamin B6), which has been shown to prevent peripheral neuropathy. The other drugs do not have this action.
Answer to Question 2
Correct Answer: 1,4
Rationale 1: The initial phase of therapy includes 2 months of daily therapy with isoniazid.
Rationale 2: The initial phase of therapy does not include 9 months of ethambutol therapy.
Rationale 3: The initial phase of therapy does not include 4 months of daily ethamubutol therapy.
Rationale 4: The initial phase of therapy includes 2 months of daily therapy with rifampin.
Rationale 5: The initial phase of therapy does not include pyrazinamide two to three times a week for 4 months.
Global Rationale: Initial treatment includes two months of daily therapy with isoniazid, rifampin (Rifadin, Rimactane), pyrazinamide (PZA), and ethambutol (Myambutol). If C&S results show that the strain is sensitive to the first three drugs, ethambutol is dropped from the regimen
Critical thinking involves analysis in which the nurse examines patient data available from a variet
Weber test: Place the base of the tuning fork on top of the client’s head.
Entry level nurse competencies
Measuring the client’s height with a platform scale
Nurse measuring the recumbent height of a toddler